Will Canopy Growth Corp (TSX:WEED) Hit $100 This Year?

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has been generating a lot of hype once again now that investors have gotten a glimpse of the company’s big plans for the U.S. market.

| More on:

Canopy Growth (TSX:WEED)(NYSE:CGC) has been on the rise again. Last week, the stock closed at over $67 — the last time it did that was back in late January. The last time the share price closed at over $70 was back in October, right around legalization and before pot stocks took a big hit.

Now, with news of Canopy Growth having a deal in place for a big U.S. company, and with it looking to expand its operations south of the border, investors are feeling very bullish about the stock once more. The big question for me is whether there’s enough excitement surrounding the stock to push it to the $100 mark.

Let’s take a look at why it might happen as well as why it might not.

How Canopy Growth could reach $100

By no means am I going to say that Canopy Growth is a cheap stock. Currently, it trades at around 150 times its sales, and investors have proven they are willing to pay big premiums for the top pot stock in the industry. However, that’s actually a lower multiple than what other stocks in the industry are trading at. If Canopy Growth is simply able to generate more hype around it and trade at a multiple of more than 220 times its sales, that would mean the stock would be trading at $100 per share.

That would require a lot of speculators to bid up the stock, and given how volatile marijuana stocks have been lately, it’s not something I would expect on happening any time soon. However, with the company releasing its quarterly earnings soon, we’re likely to see another big boost in sales in what will be Canopy Growth’s first full quarter of the recreational pot market being open for business.

Even if the company simply matches last quarter’s performance with $83 million in revenue, that will be a $60 million increase from the prior year and put its trailing 12 months sales at $215 million. If the stock continues to trade at around 150 times earnings, a higher sales number would put it close to $100.

Why the stock might not reach $100

Even if Canopy Growth has a solid quarter, investors may not be willing to pay such high multiples to sales on cannabis stocks. With there still being a lot of uncertainty surrounding the industry in both Canada and the U.S., we saw investors cool off of marijuana stocks late last year. And although we’ve seen rallies happen since then, over the long term the sustainability might not be there.

For Canopy Growth to reach $100 and not split its shares, that would mean its market cap would be north of $34 billion, putting it right around where blue-chip stocks like Rogers and Telus are currently being valued. Shopify, which has generated a lot of sales over the years and been one of the hottest stocks on the TSX, could end up being valued lower than Canopy Growth if the pot stock would soar to those heights. I would expect there to be a lot of resistance from investors to prevent Canopy Growth from getting so big, as the aforementioned stocks have very strong track records and have generated a lot more in sales to warrant those high valuations.

Bottom line

Even with a good quarter, I wouldn’t expect Canopy Growth to reach $100 this year. Investors have been a bit more hesitant on pot stocks lately, and it’s important to note that although they’ve recovered, they’ve yet to reach the peaks of last year, and that’s with sales being much stronger.

Fool contributor David Jagielski has no position in any of the stocks mentioned. Tom Gardner owns shares of Shopify. The Motley Fool owns shares of Shopify and Shopify. Shopify is a recommendation of Stock Advisor Canada.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »